BOT revenue up 487% to $33.8M; Sofdra prescriptions up 527%
BOT reported revenue up 487% to $33.8M, with a narrower net loss and Sofdra prescriptions up 527%, per TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.